Vés al contingut

A phase 3, multicentre, randomised, double-blind, vehicle-controlled, parallel-group study to evaluate, the efficacy and safety of tribanulib 10 mg, ointment applied to a treatment, field larger than 25 cm and up to 10 cm in adult patients with actinic keratosis.

Obert
  • Codi protocol: M-14867-33
  • Codi EudraCT: No aplica
  • Grup de recerca: Recerca Biomèdica en Melanoma
  • Servei: Dermatologia
  • Investigador/a principal:  Ferrándiz Pulido, Carla
  • Malaltia: Tumors
  • Fase: Fase III
  • Estat: Reclutant voluntaris